Factor VIII gene therapy - Avigen
Alternative Names: Coagulin A™; Haemophilia A gene therapyLatest Information Update: 02 Oct 2021
Price :
$50 *
At a glance
- Originator Avigen
- Class Blood coagulation factors; Coagulants
- Mechanism of Action Blood coagulation factor replacements; Factor X stimulants; Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Haemophilia A